Table 2.
Baseline characteristics of patients included in the internal pilot study
| STEMI (n=30) | NSTEMI (n=15) | p Value | |
|---|---|---|---|
| Age (years) | 62.3±8.8 | 63.9±9.7 | 0.51 |
| Age ≥70 years | 6 (20.0%) | 4 (26.7%) | 0.89 |
| Female | 6 (20.0%) | 5 (33.3%) | 0.53 |
| BMI (kg/m2) | 28.6±4.1 | 27.8±4.2 | 0.76 |
| Hypertension | 10 (33.3%) | 10 (66.7%) | 0.036 |
| Diabetes mellitus | 6 (20.0%) | 2 (13.3%) | 0.89 |
| Dyslipidaemia | 27 (90.0%) | 14 (93.3%) | 0.85 |
| Current smoker | 13 (43.3%) | 5 (33.3%) | 0.52 |
| Prior MI | 0 | 2 (13.3%) | n/a |
| Prior PCI | 2 (6.7%) | 3 (20.0%) | 0.4 |
| Prior CABG | 0 | 0 | n/a |
| Congestive heart failure | 0 | 0 | n/a |
| Non-haemorrhagic stroke | 0 | 0 | n/a |
| Peripheral arterial disease | 1 (3.3%) | 2 (13.3%) | 0.21 |
| Chronic renal disease | 0 | 0 | n/a |
| Chronic obstructive pulmonary disease | 0 | 0 | n/a |
| Gout | 1 (3.3%) | 1 (6.7%) | n/a |
| Morphine use during current MI | 17 (56.7%) | 6 (40.0%) | 0.29 |
Data are presented as mean±SD or number (%).
BMI, body mass index; CABG, coronary artery bypass surgery; MI, myocardial infarction; n/a, not available; NSTEMI, non-ST-elevation myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.